Julia G. Gorey

1.7k total citations
21 papers, 1.3k citations indexed

About

Julia G. Gorey is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Julia G. Gorey has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in Julia G. Gorey's work include Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Schizophrenia research and treatment (5 papers). Julia G. Gorey is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Schizophrenia research and treatment (5 papers). Julia G. Gorey collaborates with scholars based in United States, Germany and Czechia. Julia G. Gorey's co-authors include Douglas W. Jones, Daniel R. Weinberger, Richard Coppola, Michael B. Knable, Andreas Heinz, Kan Sam Lee, Steven S. Wolf, Thomas M. Hyde, Markku Linnoila and Daniel R. Weinberger and has published in prestigious journals such as Science, American Journal of Psychiatry and Neurology.

In The Last Decade

Julia G. Gorey

21 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia G. Gorey United States 16 717 382 366 342 293 21 1.3k
Tiina Pohjalainen Finland 14 908 1.3× 404 1.1× 409 1.1× 428 1.3× 298 1.0× 15 1.7k
Ernst Franzek Germany 26 560 0.8× 502 1.3× 468 1.3× 918 2.7× 310 1.1× 83 2.2k
John Gatley United States 12 701 1.0× 262 0.7× 391 1.1× 198 0.6× 124 0.4× 15 1.2k
Y.‐S. Ding United States 8 936 1.3× 254 0.7× 550 1.5× 392 1.1× 102 0.3× 10 1.7k
G J Wang United States 12 1.2k 1.7× 447 1.2× 558 1.5× 348 1.0× 130 0.4× 14 1.9k
Tero Hallikainen Finland 14 572 0.8× 229 0.6× 170 0.5× 393 1.1× 239 0.8× 18 1.2k
Buyean Lee United States 11 879 1.2× 288 0.8× 635 1.7× 206 0.6× 180 0.6× 12 1.4k
Xiaoyan Xu United States 19 642 0.9× 210 0.5× 426 1.2× 331 1.0× 208 0.7× 28 1.2k
C. Gautier United States 7 590 0.8× 186 0.5× 438 1.2× 233 0.7× 152 0.5× 14 1.3k
G.‐J. Wang United States 6 744 1.0× 307 0.8× 359 1.0× 137 0.4× 498 1.7× 7 1.6k

Countries citing papers authored by Julia G. Gorey

Since Specialization
Citations

This map shows the geographic impact of Julia G. Gorey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia G. Gorey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia G. Gorey more than expected).

Fields of papers citing papers by Julia G. Gorey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia G. Gorey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia G. Gorey. The network helps show where Julia G. Gorey may publish in the future.

Co-authorship network of co-authors of Julia G. Gorey

This figure shows the co-authorship network connecting the top 25 collaborators of Julia G. Gorey. A scholar is included among the top collaborators of Julia G. Gorey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia G. Gorey. Julia G. Gorey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heinz, Andreas, Douglas W. Jones, Julia G. Gorey, et al.. (2004). Depletion and restoration of endogenous monoamines affects β-CIT binding to serotonin but not dopamine transporters in non-human primates. Journal of neural transmission. Supplementum. 29–38. 23 indexed citations
2.
Heinz, Andreas, Douglas W. Jones, Julia G. Gorey, et al.. (2003). Serotonin transporter availability correlates with alcohol intake in non-human primates. Molecular Psychiatry. 8(2). 231–234. 40 indexed citations
3.
Raedler, Thomas J., Michael B. Knable, Douglas W. Jones, et al.. (2002). In Vivo Determination of Muscarinic Acetylcholine Receptor Availability in Schizophrenia. American Journal of Psychiatry. 160(1). 118–127. 179 indexed citations
4.
Heinz, Andreas, Richard C. Saunders, Bhaskar Kolachana, et al.. (1999). Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage. Synapse. 32(2). 71–79. 45 indexed citations
5.
Heinz, Andreas, Richard C. Saunders, Bhaskar Kolachana, et al.. (1999). Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage. Synapse. 32(2). 71–79. 4 indexed citations
6.
Heinz, Andreas, Paul Ragan, Douglas W. Jones, et al.. (1998). Reduced Central Serotonin Transporters in Alcoholism. American Journal of Psychiatry. 155(11). 1544–1549. 242 indexed citations
7.
Heinz, Andreas, Michael B. Knable, Richard Coppola, et al.. (1998). Psychomotor slowing, negative symptoms and dopamine receptor availability—an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients. Schizophrenia Research. 31(1). 19–26. 99 indexed citations
8.
Heinz, Andreas, J. Dee Higley, Julia G. Gorey, et al.. (1998). In Vivo Association Between Alcohol Intoxication, Aggression, and Serotonin Transporter Availability in Nonhuman Primates. American Journal of Psychiatry. 155(8). 1023–1028. 118 indexed citations
9.
Chefer, Svetlana I., Andrew G. Horti, Kan Sam Lee, et al.. (1998). In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography. Life Sciences. 63(25). PL355–PL360. 52 indexed citations
10.
Heinz, Andreas, Michael B. Knable, Steven S. Wolf, et al.. (1998). Tourette's syndrome. Neurology. 51(4). 1069–1074. 70 indexed citations
11.
Egan, Michael F., et al.. (1997). Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. The British Journal of Psychiatry. 171(6). 574–577. 42 indexed citations
12.
Heinz, Andreas, Douglas W. Jones, Julia G. Gorey, et al.. (1997). Analysis of the metabolites of [I-123]?-CIT in plasma of human and nonhuman primates. Synapse. 25(3). 306–308. 4 indexed citations
13.
Wolf, Steven S., Douglas W. Jones, Michael B. Knable, et al.. (1996). Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding. Science. 273(5279). 1225–1227. 188 indexed citations
14.
Pickar, D., Daniel R. Weinberger, Richard Coppola, et al.. (1996). Individual variation in D2 dopamine receptor occupancy in clozapine- treated patients. American Journal of Psychiatry. 153(12). 1571–1578. 48 indexed citations
15.
Breier, Alan, Richard Coppola, Igor Elman, et al.. (1996). D2 Receptor occupancy in risperidone and clozapine-treated schizophrenics. Biological Psychiatry. 39(7). 513–514. 8 indexed citations
16.
Knable, Michael B., Douglas W. Jones, Richard Coppola, et al.. (1995). Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.. PubMed. 36(7). 1216–25. 46 indexed citations
17.
Sunderland, Trey, Giuseppe Esposito, Susan Molchan, et al.. (1995). Differential cholinergic regulation in Alzheimer's patients compared to controls following chronic blockade with scopolamine: a SPECT study. Psychopharmacology. 121(2). 231–241. 30 indexed citations
18.
Knable, Michael B., et al.. (1995). I-123 IBZM spect in neuroleptic-free schizophrenic patients. Schizophrenia Research. 15(1-2). 88–88. 1 indexed citations
19.
Weinberger, D.R., David W. Jones, Trey Sunderland, et al.. (1992). IN VIVO IMAGING OF CEREBRAL MUSCARINIC RECEPTORS WITH 1-123 QNB AND SPECT: STUDIES IN NORMAL SUBJECTS AND PATIENTS WITH DEMENTIA. Clinical Neuropharmacology. 15. 194A–195A. 4 indexed citations
20.
Weinberger, D.R., Douglas W. Jones, Richard C. Reba, et al.. (1992). A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia. Journal of Neuropsychiatry. 4(3). 239–248. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tiina Pohjalainen Breakdown of academic impact, for papers by Ernst Franzek Breakdown of academic impact, for papers by John Gatley Breakdown of academic impact, for papers by Y.‐S. Ding Breakdown of academic impact, for papers by G J Wang Breakdown of academic impact, for papers by Tero Hallikainen Breakdown of academic impact, for papers by Buyean Lee Breakdown of academic impact, for papers by Xiaoyan Xu Breakdown of academic impact, for papers by C. Gautier Breakdown of academic impact, for papers by G.‐J. Wang
Rankless by CCL
2026